Target intelligence / Profile preview

Urea transporter A and B (SLC14A1 and SLC14A2) (UT-A/UT-B)

Target
UT-A/UT-B
Molecular classification
Transporter, Solute carrier family
01

Overview

Urea transporters UT-A and UT-B are integral membrane proteins belonging to the solute carrier family 14 (SLC14) that facilitate the passive movement of urea across biological membranes (UniProt, Q13336, Q15848). UT-A isoforms, encoded by the SLC14A2 gene, are predominantly expressed in the renal inner medullary collecting duct and the thin descending limb of Henle's loop, where they are essential for the urinary concentrating mechanism (PubMed, PMID: 21930148). UT-B, encoded by the SLC14A1 gene, is found in the vasa recta and red blood cells, facilitating urea countercurrent exchange to maintain the medullary osmotic gradient (NIH, PMC3189314). These transporters are significant therapeutic targets for the development of 'urearetics,' a novel class of diuretics that promote water excretion without the electrolyte imbalances typically associated with loop diuretics (PubMed, PMID: 24509434). By inhibiting UT-A and UT-B, these compounds disrupt the intrarenal urea recycling process, thereby reducing the kidney's ability to concentrate urine and treating conditions such as congestive heart failure and cirrhosis-related edema (PubMed, PMID: 29108052).

Other names
Solute carrier family 14 member 1Solute carrier family 14 member 2Kidd blood group antigenHUT11UT1UT2Urea transporter 1Urea transporter 2
02

Mechanism of action

Inhibition of facilitated urea transport across cell membranes in the renal medulla, which disrupts the intrarenal urea gradient and reduces the osmotic driving force for water reabsorption, leading to urearesis (PubMed, PMID: 24509434).

03

Biological functions

Facilitated urea transportUrinary concentration mechanismMaintenance of medullary osmotic gradientUrea recyclingNitrogen homeostasis
04

Disease associations

Heart failureCirrhosisHypertensionEdemaSyndrome of inappropriate antidiuretic hormone secretion (SIADH)Nephrogenic diabetes insipidus
05

Safety considerations

Potential for uremia (elevated blood urea nitrogen)Dehydration due to excessive water lossOff-target effects in the central nervous system where UT-B is expressedPotential impact on red blood cell urea permeability (Kidd-null phenotype simulation)
06

Interacting drugs

Thiourea (experimental)

5 more in the full profile.

07

Biomarkers

Urine osmolalityUrinary urea concentrationPlasma urea-to-creatinine ratioFractional excretion of urea

Beyond the preview

Go deeper on Urea transporter A and B (SLC14A1 and SLC14A2) (UT-A/UT-B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urea transporter A and B (SLC14A1 and SLC14A2) (UT-A/UT-B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call